Mathieu Seynaeve
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine) in patients with treatment-resistant depression.
Journal: Journal of psychopharmacology (Oxford, England)
Published: February 27, 2026
Psychedelic Therapy: A Primer for Primary Care Clinicians-5-Methoxy-N,N-Dimethyltryptamine.
Journal: American journal of therapeutics
Published: February 20, 2026
Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.
Journal: Nature medicine
Published: January 21, 2026
Psychological change processes in alcohol use disorder: A qualitative study of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) with cognitive behavioural therapy.
Journal: Addiction (Abingdon, England)
Published: October 19, 2025
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trial.
Journal: Addiction (Abingdon, England)
Published: June 11, 2025
Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults.
Journal: Scientific reports
Published: October 23, 2024
Improving the estimation of the lean meat percentage in pig carcasses using Box-Cox transformation and additional carcass parameters.
Journal: Meat science
Published: May 14, 2024
Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants.
Journal: Journal of psychopharmacology (Oxford, England)
Published: April 15, 2024
Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.
Journal: Headache
Published: November 13, 2023
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
Journal: The New England journal of medicine
Published: November 02, 2022
Views on Using Psychoactive Substances to Self-Manage Functional Neurological Disorder: Online Patient Survey Results.
Journal: The Journal of neuropsychiatry and clinical neurosciences
Published: May 17, 2022
Last Updated: 09/26/2026